Ginwa Enterprise (Group) Inc. (SHA:600080)

China flag China · Delayed Price · Currency is CNY
7.89
-0.04 (-0.50%)
Feb 4, 2026, 3:00 PM CST
13.69%
Market Cap2.78B +0.4%
Revenue (ttm)550.44M -5.3%
Net Income78.32M
EPS0.23
Shares Out352.71M
PE Ratio34.96
Forward PEn/a
Dividend0.03 (0.38%)
Ex-Dividend Daten/a
Volume5,405,800
Average Volume7,667,834
Open7.92
Previous Close7.93
Day's Range7.78 - 7.92
52-Week Range6.23 - 9.35
Beta0.30
RSI48.28
Earnings DateApr 25, 2026

About Ginwa Enterprise (Group)

Ginwa Enterprise (Group) Inc. researches, develops, produces, markets, and sells traditional Chinese medicines, biological drugs, and chemical drugs primarily in China. The company offers a range of orthopaedics, immunity, children, and general medicines in various dosage forms, including tablets, capsules, granules, powders, mixtures, oral solutions, syrups, and external solutions. It is also involved in the pharmaceutical logistics activities. The company was founded in 1996 and is headquartered in Xi'an, China. [Read more]

Sector Healthcare
Founded 1996
Employees 588
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600080
Full Company Profile

Financial Performance

Financial Statements